Allogeneic Transplantation
Myeloproliferative Neoplasms Trials (MPN: ET, MF, PV)
COMIRB: 22-0305
A Phase 3 Study of the Hepcidin Mimetic Rusfertide (PTG-300) in Patients with Polycythemia Vera
Principal Investigator: Brandon McMahon
Eligibility: Ages ≥ 18; Diagnosed polycythemia vera; ECOG of ≤2
COMIRB: 22-0130
A Phase 1, Open-Label, Safety and Tolerability Study of INCB057643 in Participants with Myelofibrosis and Other Advanced Myeloid Neoplasms
PI: Brandon McMahon
Eligibility: Ages ≥ 18; Relapsed or refractory MF, MDS, or MDS/MPN (Part 1); ECOG of ≤2
COMIRB: 25-0787
A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms
PI: Mat Angelos
Eligibility: Be greater than or equal to (>=) 18 years of age plus other inclusion and exclusion criteria.
COMIRB: 25-1016
(HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis
PI: Cassandra Duarte
Eligibility: Ages ≥ 18; other protocol-defined criteria apply.
COMIRB: 25-2635
An Observational Study in Participants With Indolent Systemic Mastocytosis (ISM)
PI: Cassandra Duarte
Eligibility: Ages ≥ 18; other protocol-defined criteria apply.
Request an Appointment
If you would like to schedule an appointment, please give us a call.
Our intake coordinator will help you navigate the process of becoming a new patient including helping you obtain the necessary referrals, get the necessary medical records transferred, and coordinate care with your existing physicians. We are available to answer your questions about our clinic, your treatment, and participation in ongoing clinical trials.